FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

14 letters match. Newest first.

  1. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  2. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  3. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  4. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  5. Lux Therapeutics LLC dba Ponya Therapeutics LLC

    FDA warns Lux Therapeutics over unvalidated TheraMend amniotic patches and records, citing inadequate response and Luxegen distribution concerns.

    High risk
  6. InVia Fertility Specialists, PLLC

    FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.

    High risk
  7. New Mexico Lions Sight Conservation Foundation, Inc. dba New Mexico Lions Eye Bank

    FDA warns New Mexico eye bank over distributing eye tissue from two donors with sepsis.

    High risk
  8. Indiana Lions Eye Bank, Inc. dba VisionFirst Indiana Lions Eye Bank

    Indiana Lions Eye Bank distributed ocular tissue from donors with sepsis after failing to screen them as ineligible.

    High risk
  9. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  10. Washington Fertility Center

    FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.

    High risk
  11. The New Hope Center for Reproductive Medicine

    FDA warns Virginia Beach fertility center over incomplete donor screening and testing for reproductive tissue.

    High risk
  12. Invitrx Therapeutics, Inc.

    Invitrx Therapeutics made unapproved umbilical cord and exosome products and had serious manufacturing deviations.

    High risk
  13. Zhang Medical P.C. dba New Hope Fertility Center

    New Hope Fertility Center failed to properly screen and test oocyte and semen donors for communicable diseases, FDA says.

    High risk
  14. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk